Alvotech share price logo

Alvotech Share Price

NASDAQ: ALVO

Small Cap

$3.60

-0.02

(-0.41%)

as on

Alvotech Stock Performance

as on April 18, 2026 at 6:59 am IST

  • Day's High

    $3.60
    $3.75

    4.17%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.03
    $11.85
    downward going graph

    15.83%

    Downside

    229.17%

    Upside

    downward going graph

Alvotech share price movements today

Previous Close
$3.62
Open
$3.65
Volume
307.9K
Day's Low - High
$3.60 - $3.75
52 Week Low - High
$3.03 - $11.85

Alvotech Historical Returns

1 Month Return
-5 %
3 Month Return
-26.63 %
1 Year Return
-56.45 %
3 Year Return
-63.94 %
5 Year Return
0 %

Alvotech Stock Fundamentals & Key Indicators

Check Alvotech market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.1B

EPS (TTM)

0.0063

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.58%

PE Ratio (TTM)

36.1

Industry PE ratio

7.338620689655173

PEG Ratio

0

EBITDA

104.0M

Revenue (TTM)

588.9M

Profit Margin

4.74%

Return On Equity TTM

0.00%

Alvotech Stock Valuation

Track how Alvotech P/E has moved over time to understand its valuation trends.

Alvotech in the last 5 years

  • Overview

  • Trends

Lowest (-134.80x)

March 31, 2025

Industry (7.34x)

April 18, 2026

Today (36.10x)

April 18, 2026

Highest (194.45x)

March 31, 2026

LowHigh

Today’s Price to Earnings Ratio: 36.10x

Alvotech vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alvotech with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Alvotech image
Alvotech
BUY$1.1BNA36.14.74%
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$25.8BNA21.1241.94%
Viatris Inc image
Viatris Inc
HOLD$16.3B9.55%NA-24.58%
Haleon plc image
Haleon plc
BUY$43.4BNA19.515.11%
Zoetis Inc image
Zoetis Inc
BUY$51.7B-26.99%19.7728.24%

Stock Returns calculator for Alvotech Stock including INR - Dollar returns

The Alvotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Alvotech investment value today

Current value as on today

₹47,178

Returns

-₹52,822

(-52.82%)

Returns from Alvotech Stock

-₹56,574 (-56.57%)

Dollar Impact

₹3,752 (+3.75%)

Analyst Recommendation on Alvotech Stock

Based on 11 analysts

BUY

72.73%

Buy

27.27%

Hold

0.00%

Sell

Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Alvotech. Average target price of $13.83

Alvotech Share Price Target

Get share price movements and forecasts by analysts on Alvotech.

What analysts predicted

73.97%UPSIDE

Target Price

$13.83

Current Price

$3.6

Analyzed by

11 Analysts

Target

$13.83

Alvotech target price $13.83, a slight upside of 73.97% compared to current price of $3.6. According to 11 analysts rating.

Alvotech Stock’s Investor Sentiment and Interest

Search interest for Alvotech Stock has increased by 76% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:76% versus previous 30 day period

Alvotech Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
17
53
36
198
102
151
132
173
113
166
Gross Profit
-18
-3
16
153
63
70
67
99
78
105
Operating Income
-88
-79
-48
91
12
13
10
18
1
48
EBITDA
-149
-72
-33
-16
138
-119
137
51
3
-114
Interest Expense
43
68
184
42
90
159
35
36
36
40
Depreciation
6
6
7
7
8
8
8
8
10
10
Income Before Tax
-205
-308
-225
76
-24
-44
93
9
-6
39
Income Tax Expense
-17
-32
-6
11
-13
22
-16
-22
0
148
Net Income
-188
-276
-218
65
-11
-66
109
32
-5
-108
Net Profit Margin
-1058.63%
-517.99%
-593.53%
32.82%
-11.07%
-44.29%
82.61%
18.49%
-4.58%
-65.27%

Alvotech Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
31
66
36
83
91
489
586
Gross Profit
31
66
36
18
-69
304
350
Operating Income
-61
-137
-235
-346
-354
69
78
EBITDA
-99
-177
-18
-439
-493
-32
323
Interest Expense
95
97
112
91
134
157
149
Depreciation
14
16
18
20
24
31
37
Income Before Tax
-209
-291
-149
-551
-651
-217
136
Income Tax Expense
0
-121
-47
-38
-99
14
108
Net Income
-209
-170
-101
-513
-551
-231
27
Net Profit Margin
-657.55%
-255.26%
-276.04%
-618.55%
-603.42%
-47.35%
4.76%

Alvotech Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-276
-218
65
-11
-66
109
32
-5
-108
Operating Cash Flow
-67
-75
-50
-71
-39
12
55
-55
-62
Investing Cash Flow
-10
-3
-7
22
-31
-20
-28
-39
-15
Financing Cash Flow
20
133
4
155
4
-5
83
-13
206
Change in Cash
-57
53
-53
107
-66
-12
112
-108
129

Alvotech Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-170
-101
-513
-551
-231
27
Operating Cash Flow
-74
-228
-312
-312
-236
-50
Investing Cash Flow
-16
-40
-63
-46
-18
-104
Financing Cash Flow
55
254
424
301
297
270
Change in Cash
-35
-14
48
-55
40
120

Alvotech News & Key Events

  • img

    Today's Timeline - 10 November

    Mon, 02:30 PM

    -

    UK High Court rules in favor of Alvotech, allowing AVT06 manufacturing and market entry post-Eylea SPC expiry.

Insights on Alvotech

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 113.95M → 166.36M (in $), with an average increase of 31.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 154.6% return, outperforming this stock by 218.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 103.9% return, outperforming this stock by 160.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 109.68M → -108.58M (in $), with an average decrease of 722.7% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, ALVO stock has moved down by -58.5%

About Alvotech

Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company provides AVT02, a high concentration, low-volume adalimumab formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ankylosing spondylitis ulcerative colitis, and other indications; AVT04, a biosimilar to Stelara to treat various inflammatory conditions comprising psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT06, a biosimilar to Eylea to treat various conditions, such as neovascular age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema and diabetic retinopathy; and AVT03, a biosimilar to Xgeva and Prolia to treat prevent bone fracture, spinal cord compression, and the need for radiation or bone surgery in patients with certain types of cancer, as well as prevent bone loss and increase bone mass. In addition, it offers AVT05, a biosimilar to Simponi and Simponi Aria to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and other indications; AVT16, a biosimilar to an Entyvio product for the treatment of adult patients with moderate to severe ulcerative colitis and moderate to severely active Crohn's disease; AVT23, a biosimilar to Xolair to treat allergic asthma, chronic spontaneous urticaria (CSU), and nasal polyp; and AVT33, a biosimilar to Keytruda product which is in early phase development. Alvotech was founded in 2013 and is based in Luxembourg, Luxembourg.
OrganisationAlvotech
Headquarters9, Rue de Bitbourg, Luxembourg, Luxembourg, 1273
IndustryDrug Manufacturers - Specialty & Generic
CEOMs. Lisa Graver
E-voting on sharesClick here to vote

Key Management of Alvotech

Name

Title

Mr. Vilhelm Robert Wessman

Founder & Executive Chairman

Ms. Lisa Graver

Chief Executive Officer

Mr. Joseph E. McClellan

Chief Operating Officer

Ms. Tanya Zharov

General Counsel

Mr. Anthony M. Maffia III

Chief Quality & Regulatory Officer

Ms. Linda Jonsdottir

Chief Financial Officer

Mr. Benedikt Stefansson

Vice President of Investor Relations & Global Communications

Ms. Sarah Macleod

Head of Global Communications

Ms. Kathryn Gunnarsson

Senior Vice President of Global Talent & People Experience

Dr. Balaji Venkataramanan Prasad M.D.

Chief Strategy Officer

FAQs

What is Alvotech share price today?

Alvotech share price today is $3.6 as on at the close of the market. Alvotech share today touched a day high of $3.75 and a low of $3.6.

What is the 52 week high and 52 week low for Alvotech share?

Alvotech share touched a 52 week high of $11.85 on and a 52 week low of $3.03 on . Alvotech stock price today i.e. is closed at $3.6,which is 69.62% down from its 52 week high and 18.81% up from its 52 week low.

What is Alvotech's market capitalisation today?

Alvotech market capitalisation is $0.00T as on .

How to invest in Alvotech Stock (ALVO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alvotech on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alvotech Shares that will get you 0.4167 shares as per Alvotech share price of $3.6 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Alvotech Stock (ALVO) from India?

Indian investors can start investing in Alvotech (ALVO) shares with as little as ₹92.768 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in Alvotech stock (as per the Rupee-Dollar exchange rate as on ). Based on Alvotech share’s latest price of $3.6 as on April 18, 2026 at 1:29 am IST, you will get 2.7778 shares of Alvotech. Learn more about fractional shares .